BioSpace News Archive

Medicenna Therapeutics Corp. today announced presentation of data from two preclinical programs that demonstrate the anti-tumor activity of the Company’s anti-PD1-IL-2 (aka MDNA223) BiSKIT (Bi-functional SuperKines for ImmunoTherapy) and long-acting IL-4/IL-13 super-antagonist (aka MDNA413).

MEDSIR, an international company specialized in the strategic design of clinical trials is pleased to announce the appointment of Jyoti Mundra, PhD, as Chief Business Officer.

Phio Pharmaceuticals Corp. today announced that its research partner, Helmholtz Munich, presented preclinical data showing that Phio’s lead clinical product PH-762.

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced financial results for its fiscal fourth quarter and fiscal year ended June 30, 2022.

Marinus Pharmaceuticals, Inc. today announced the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services, exercised its first contract option, valued at approximately $12.3 million.

Better Therapeutics, Inc today announced that it has submitted a de novo classification request to the U.S. Food and Drug Administration (FDA) seeking marketing authorization for BT-001, its potentially first-in-class digital therapeutic designed to use CBT to treat Type 2 Diabetes (T2D) in patients 18 years and older.

Mammoth Biosciences , a biotech company harnessing next-generation CRISPR technology to detect and cure disease, has been chosen by Endpoints News Editor John Carroll as one of the most promising biotech startups for this year’s Endpoints 11 annual special report.

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA, announced that it has signed a definitive agreement under which Merck Animal Health will acquire Vence from its founders and shareholders.

Ludwig Enterprises , a leading-edge innovator of genetic inflammatory biomarkers to diagnose and manage chronic diseases, is pleased to announce that the Company has filed a patent on proprietary technology, the Ludwig mRNA Inflammatory Index.

Dynatronics Corporation, a leading manufacturer of athletic training, physical therapy, and rehabilitation products, reported financial results for its fourth quarter and fiscal year ended June 30, 2022, and provided an update on recent business highlights.